Residential medication management, also known as medication therapy management, is an agreement among a patient (or the appropriate caregiver), the patient’s pharmacist, and other healthcare professionals that promotes effective and safe uses of medication in order to achieve the desired results from medication-based therapy. This includes analytical, educational, and monitoring services offered by pharmacists to assist patients in getting the best results from their medication by increasing their understanding of the appropriate medications, controlling costs, and preventing health complications due to drug conflicts and interactions. Many mental health issues can be addressed through residential medication management, including PTSD, co-occurring disorders, bipolar disorders.
Residential medication management was created by Congress as part of the Medicare Modernization Act of 2003, which established the requirement that every sponsor of the Medicare Part D plan provide a residential medication management program to certain beneficiaries of Medicare, beginning in 2006. Those receiving the benefits of residential medication management include Medicare members with multiple chronic conditions, those taking Part D drugs, and those likely to incur costs exceeding a specified level due to receiving Part D drugs. Patients not falling under these categories, however, may also benefit from residential medication management; many health care plans utilize residential medication management programs to proactively reduce health care costs and prevent complications due to medication conflicts.